← Back to ONCO

Onconetix, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$0$0$0.3$0.1$0.1$0.4$0.7$0.4
−$2.9−$4.2−$8.8−$2.4−$8.5−$3.8−$14−$11
−$1.28−$6.71−$6.25−$237.91−$227.25−$249.08−$2191.59−$20.08
2.20.61.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.